Allergy pill may ease agonizing bone pain for cancer patients
NCT ID NCT05421416
Summary
This study is testing whether the common allergy medication loratadine can prevent or reduce severe bone pain caused by drugs used to prepare for stem cell transplants. The trial involves 78 adults with lymphoma or multiple myeloma who are scheduled for stem cell transplants. Participants will receive either loratadine or a placebo pill while taking the transplant preparation drugs to see which group experiences less bone pain and maintains better quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
Conditions
Explore the condition pages connected to this study.